Literature DB >> 27053572

Left Ventricular Hypertrophy in Rhesus Macaques (Macaca mulatta) at the California National Primate Research Center (1992-2014).

J Rachel Reader1, Don R Canfield2, Jennifer F Lane3, Sreetharan Kanthaswamy4, Amir Ardeshir2, A Mark Allen2, Ross P Tarara2.   

Abstract

Necropsy records and associated clinical histories from the rhesus macaque colony at the California National Primate Research Center were reviewed to identify mortality related to cardiac abnormalities involving left ventricular hypertrophy (LVH). Over a 21-y period, 162 cases (female, 90; male, 72) of idiopathic LVH were identified. Macaques presented to necropsy with prominent concentric hypertrophy of the left ventricle associated with striking reduction of the ventricular lumen. Among all LVH cases, 74 macaques (female, 39; male, 35), mostly young adults, presented for spontaneous (sudden) death; more than 50% of these 74 cases were associated with a recent history of sedation or intraspecific aggression. The risk of sudden death in the 6- to 9-y-old age group was significantly higher in male macaques. Subtle histologic cardiac lesions included karyomegaly and increased cardiac myocyte diameter. Pedigree analyses based on rhesus macaque LVH probands suggested a strong genetic predisposition for the condition. In humans, hypertrophic cardiomyopathy (HCM) is defined by the presence of unexplained left ventricular hypertrophy, associated with diverse clinical outcomes ranging from asymptomatic disease to sudden death. Although the overall risk of disease complications such as sudden death, end-stage heart failure, and stroke is low (1% to 2%) in patients with HCM, the absolute risk can vary dramatically. Prima facie comparison of HCM and LVH suggest that further study may allow the development of spontaneously occurring LVH in rhesus macaques as a useful model of HCM, to better understand the pathogenesis of this remarkably heterogeneous disease.

Entities:  

Mesh:

Year:  2016        PMID: 27053572      PMCID: PMC4825967     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  46 in total

1.  Asymmetrical hypertrophy of the heart in young adults.

Authors:  D TEARE
Journal:  Br Heart J       Date:  1958-01

2.  Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1.

Authors:  J A Jarcho; W McKenna; J A Pare; S D Solomon; R F Holcombe; S Dickie; T Levi; H Donis-Keller; J G Seidman; C E Seidman
Journal:  N Engl J Med       Date:  1989-11-16       Impact factor: 91.245

3.  Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy.

Authors:  B J Maron; T J Anan; W C Roberts
Journal:  Circulation       Date:  1981-04       Impact factor: 29.690

4.  Stereological measurement of cellular and subcellular hypertrophy and hyperplasia in the papillary muscle of adult rat.

Authors:  P Anversa; G Olivetti; M Melissari; A V Loud
Journal:  J Mol Cell Cardiol       Date:  1980-08       Impact factor: 5.000

5.  Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease.

Authors:  A M Varnava; P M Elliott; S Sharma; W J McKenna; M J Davies
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

6.  The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model.

Authors:  Christopher Semsarian; Imran Ahmad; Michael Giewat; Dimitrios Georgakopoulos; Joachim P Schmitt; Bradley K McConnell; Steven Reiken; Ulrike Mende; Andrew R Marks; David A Kass; Christine E Seidman; J G Seidman
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

7.  A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy.

Authors:  C Semsarian; M J Healey; D Fatkin; M Giewat; C Duffy; C E Seidman; J G Seidman
Journal:  J Mol Cell Cardiol       Date:  2001-11       Impact factor: 5.000

8.  Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.

Authors:  Franco Cecchi; Iacopo Olivotto; Roberto Gistri; Roberto Lorenzoni; Giampaolo Chiriatti; Paolo G Camici
Journal:  N Engl J Med       Date:  2003-09-11       Impact factor: 91.245

9.  Investigation into the use of plasma NT-proBNP concentration to screen for feline hypertrophic cardiomyopathy.

Authors:  Adonia Hsu; Mark D Kittleson; Anna Paling
Journal:  J Vet Cardiol       Date:  2009-04-22       Impact factor: 1.701

10.  Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006.

Authors:  Barry J Maron; Joseph J Doerer; Tammy S Haas; David M Tierney; Frederick O Mueller
Journal:  Circulation       Date:  2009-02-16       Impact factor: 29.690

View more
  12 in total

1.  DNA vaccination before conception protects Zika virus-exposed pregnant macaques against prolonged viremia and improves fetal outcomes.

Authors:  Koen K A Van Rompay; Rebekah I Keesler; Amir Ardeshir; Jennifer Watanabe; Jodie Usachenko; Anil Singapuri; Christina Cruzen; Eliza Bliss-Moreau; Ashley M Murphy; JoAnn L Yee; Helen Webster; Maria Dennis; Tulika Singh; Holly Heimsath; Danilo Lemos; Jackson Stuart; Kaitlyn M Morabito; Bryant M Foreman; Katherine E Burgomaster; Amy T Noe; Kimberly A Dowd; Erin Ball; Kevin Woolard; Pietro Presicce; Suhas G Kallapur; Sallie R Permar; Kathryn E Foulds; Lark L Coffey; Theodore C Pierson; Barney S Graham
Journal:  Sci Transl Med       Date:  2019-12-18       Impact factor: 17.956

2.  Pneumatosis intestinalis in an SIV-infected rhesus macaque (Macaca mulatta).

Authors:  A L Johnson; K Van Rompay; J R Reader
Journal:  J Med Primatol       Date:  2017-08-15       Impact factor: 0.667

3.  Vertebral Heart Score in Rhesus Macaques (Macaca mulatta): Generating Normal Reference Intervals and Assessing its Validity for Identifying Cardiac Disease.

Authors:  Amber R Williams; Yu Ueda; Joshua A Stern; Kari L Christe
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-04-21       Impact factor: 1.232

4.  Antemortem Screening for Left Ventricular Hypertrophy in Rhesus Macaques (Macaca mulatta).

Authors:  Andrew J Haertel; Joshua A Stern; J Rachel Reader; Abigail Spinner; Jeffrey A Roberts; Kari L Christe
Journal:  Comp Med       Date:  2016       Impact factor: 0.982

5.  Echocardiographic Parameters of Clinically Normal Geriatric Rhesus Macaques (Macacamulatta).

Authors:  Yu Ueda; Catherine T Gunther-Harrington; Christina L Cruzen; Jeffrey A Roberts; Joshua A Stern
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-07-01       Impact factor: 1.232

Review 6.  Inherited cardiomyopathies in veterinary medicine.

Authors:  Joshua A Stern; Yu Ueda
Journal:  Pflugers Arch       Date:  2018-10-03       Impact factor: 3.657

7.  MYBPC3 Haplotype Linked to Hypertrophic Cardiomyopathy in Rhesus Macaques (Macaca mulatta).

Authors:  Robert F Oldt; Kimberly J Bussey; Matthew L Settles; Joseph N Fass; Jeffrey A Roberts; J Rachel Reader; Srivathsan Komandoor; Victor A Abrich; Sreetharan Kanthaswamy
Journal:  Comp Med       Date:  2020-08-04       Impact factor: 0.982

Review 8.  A One Health Approach to Hypertrophic Cardiomyopathy.

Authors:  Yu Ueda; Joshua A Stern
Journal:  Yale J Biol Med       Date:  2017-09-25

9.  Heart Rate and Heart Rate Variability of Rhesus Macaques (Macaca mulatta) Affected by Left Ventricular Hypertrophy.

Authors:  Yu Ueda; Taylor L Slabaugh; Ashley L Walker; Eric S Ontiveros; Paul-Michael Sosa; Rachel Reader; Jeffrey A Roberts; Joshua A Stern
Journal:  Front Vet Sci       Date:  2019-01-22

10.  Heritability and Pedigree Analyses of Hypertrophic Cardiomyopathy in Rhesus Macaques (Macaca Mulatta).

Authors:  Yu Ueda; Samantha Kovacs; Rachel Reader; Jeffrey A Roberts; Joshua A Stern
Journal:  Front Vet Sci       Date:  2021-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.